Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004;2004(2):CD004804.
doi: 10.1002/14651858.CD004804.

Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings

Affiliations

Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings

K Schroeder et al. Cochrane Database Syst Rev. 2004.

Abstract

Background: Lack of adherence to blood pressure lowering medication is a major reason for poor control of hypertension worldwide. Interventions to improve adherence to antihypertensive medication have been evaluated in randomised trials but it is unclear which interventions are effective.

Objectives: To determine the effectiveness of interventions aiming to increase adherence to blood pressure lowering medication in adults with high blood pressure

Search strategy: All-language search of all articles (any year) in the Cochrane Controlled Trials Register (CCTR), MEDLINE, EMBASE, and CINAHL in April 2002.

Selection criteria: RCTs of interventions to increase adherence to blood pressure lowering medication in adults with essential hypertension in primary care, with adherence to medication and blood pressure control as outcomes

Data collection and analysis: Two authors extracted data independently and in duplicate and assessed each study according to the criteria outlined by the Cochrane Collaboration Handbook.

Main results: We included 38 studies testing 58 different interventions and containing data on 15519 patients. The studies were conducted in nine countries between 1975 and 2000. The duration of follow-up ranged from two to 60 months. Due to heterogeneity between studies in terms of interventions and the methods used to measure adherence, we did not pool the results. Simplifying dosing regimens increased adherence in seven out of nine studies, with a relative increase in adherence of 8 per cent to 19.6 per cent. Motivational strategies were successful in 10 out of 24 studies with generally small increases in adherence up to a maximum of 23 per cent. Complex interventions involving more than one technique increased adherence in eight out of 18 studies, ranging from 5 per cent to a maximum of 41 per cent. Patient education alone seemed largely unsuccessful.

Reviewers' conclusions: Reducing the number of daily doses appears to be effective in increasing adherence to blood pressure lowering medication and should be tried as a first line strategy, although there is less evidence of an effect on blood pressure reduction. Some motivational strategies and complex interventions appear promising, but we need more evidence on their effect through carefully designed RCTs.

PubMed Disclaimer

Conflict of interest statement

None.

Comment in

References

References to studies included in this review

Andrejak 2000 {published data only}
    1. Andrejak M, Genes N, Vaur L, Poncelet P, Clerson P, Carre A. Electronic pill boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimen. American Journal of Hypertension 2000;13:184‐90. - PubMed
Asplund 1984 {published data only}
    1. Asplund J, Danielson M, Ohman P. Patients' compliance in hypertension ‐ the importance of number of tablets. British Journal of Clinical Pharmacology 1984;17:547‐52. - PMC - PubMed
Baird 1984 {published data only}
    1. Baird MG, Bentley‐Taylor MM, Carruthers SG, Dawson KG, Laplante LE, Larochelle P, MacCannell KL, Marquez‐Julio A, Silverberg LR, Talbot P. A study of efficacy, tolerance and compliance of once‐daily versus twice‐daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study Group. Clinical and Investigative Medicine 1984;7(2):95‐102. - PubMed
Becker 1986 {published data only}
    1. Becker LA, Glanz K, Sobel E, Mossey J, Zinn SL, Andrews‐Knott K. A randomized trial of special packaging of antihypertensive medications. J Fam Pract 1986;22(4):357‐361. - PubMed
Blenkinsopp 2000 {published data only}
    1. Blenkinsopp AP. Extended adherence support by community pharmacists for patients with hypertension. International Journal of Pharmacy Practice 2000;8:165‐75.
Boissell 1996 {published data only}
    1. Boissell JP, Meillard O, Perrin‐Fayolle E, Ducruet T, Alamercery Y, Sassano P, Benghozi R. Comparison between a bid and tid regimen: improved compliance with no improved antihypertensive effect. The EOL Research Group. European Journal of Clinical Pharmacology 1996;50(1‐2):63‐7. - PubMed
Burrelle 1986 {published data only}
    1. Burrelle TN. Evaluation of an interdisciplinary compliance service for elderly hypertensives. Journal of Geriatric Drug Therapy 1986;1(2):23‐51`.
Burris 1991 {published data only}
    1. Burris JF, Papademetriou V, Wallin JD, Cook ME, Weidler DJ. Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension. American Journal of Medicine 1991;91(1A):22S‐8S. - PubMed
Detry 1995 {published data only}
    1. Detry JM, Block P, DeBacker G, Degaute JP. Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension. European Journal of Clinical Pharmacology 1995;47:477‐481. - PubMed
Eshelman 1976 {published data only}
    1. Eshelman FN, Fitzloff J. Effect of packaging on patient compliance with an antihypertensive medication. Current Therapeutic Research 1976;20(2):215‐9. - PubMed
Friedman 1996 {published data only}
    1. Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgers J, Carey K. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. American Journal of Hypertension 1996;9(4 Pt 1):285‐92. - PubMed
Gabriel 1977 {published data only}
    1. Gabriel M, Gagnon JP, Bryan CK. Improved patient compliance through use of a daily drug reminder chart. Americal Journal of Public Health 1977;67:968‐69. - PMC - PubMed
Girvin 1999 {published data only}
    1. Girvin B, McDermott BJ, Johnston GD. A comparison of enalapril 20mg once daily versus 10mg twice daily in terms of blood pressure lowering and patient compliance. Journal of Hypertension 1999;17:1627‐31. - PubMed
Hamilton 1993 {published data only}
    1. Hamilton GA, Roberts SJ, Johnson JM, Tropp JR, Anthony‐Odgren D, Johnson BF. Increasing adherence in patients with primary hypertension: an intervention. Health Values 1993;17:3‐11.
Hawkins 1979 {published data only}
    1. Hawkins DW, Fiedler FP, Douglas HL, Eschback RC. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. American Journal of Hospital Pharmacy 1979;36:1321‐1325. - PubMed
Haynes 1976 {published data only}
    1. Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, Johnson AL. Improvement of medication compliance in uncontrolled hypertension. Lancet 1976;i:1265‐1268. - PubMed
Johnson 1978 {published data only}
    1. Johnson AL, Taylor DW, Sackett DL, Dunnett CW, Shimizu AG. Self‐recording of blood pressure in the management of hypertension. Canadian Medical Association Journal 1978;119:1034‐1039. - PMC - PubMed
Kerr 1985 {published data only}
    1. Kerr JAC. Adherence and self‐care. Heart and Lung 1985;14(1):24‐31. - PubMed
Kirscht 1977 {published data only}
    1. Kirscht JP, Kirscht JL, Rosenstock IM. A test of interventions to increase adherence to hypertensive medical regimens. Health Education Quarterly 1977;8:261‐72. - PubMed
Leenen 1997 {published data only}
    1. Leenen FH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, Boileau G, Tanner J. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Canadian Journal of Cardiology 1997; Vol. 13, issue 10:914‐20. - PubMed
Logan 1979 {published data only}
    1. Logan AG, Milne BJ, Achber C, Campbell WP, Haynes RB. Work‐site treatment of hypertension by specially trained nurses. A controlled trial. Lancet 1979;2:1175‐1178. - PubMed
Logan 1983 {published data only}
    1. Logan AG, Milne BJ, Flanagan PT, Haynes RB. Clinical effectiveness and cost‐effectiveness of monitoring blood pressure of hypertensive employees at work. Hypertension 1983;5(6):828‐36. - PubMed
Marquez‐Contr. 1998 {published data only}
    1. Marquez‐Contreras E, Casado‐Martinez JJ, Ramos‐Perez J, Saenz‐Soubrier S, Moreno‐Garcia JP, Celotti‐Gomez B, Gascon‐Vivo J, Martin‐de‐Pablos JL. Treatment compliance in arterial hypertension: a 2‐year intervention trial through health education [Ensayo sobre la eficacia de los programas de educadion para la salud en el cumplimiento terapeutico de la hipertension arterial]. Aten‐Primaria 1998;21(4):199‐204. - PubMed
McKenney 1992 {published data only}
    1. McKenney JM, Munroe WP, Wright JTJr. Impact of an electronic medication compliance aid on long‐term blood pressure control. Journal of Clinical Pharmacology 1992;32(3):277‐83. - PubMed
Mehos 2000 {published data only}
    1. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy 2000;20:1384‐89. - PubMed
Morisky 1985 {published data only}
    1. Morisky DE, DeMuth NM, Field‐Fass M, Green LW, Levine DM. Evaluation of family health education to build social support for long‐term control of high blood pressure. Health Education Quarterly 1985;12(1):35‐50. - PubMed
Mounier‐Veh. 1998 {published data only}
    1. Mounier‐Vehier DE, Bernard C, Lequeuche B, Hotton JM, Charpentier JC. Evaluation of family health education to build social support for long‐term control of high blood pressure [Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow release]. Americal Journal of Hypertension 1998;11:478‐486. - PubMed
Nessman 1980 {published data only}
    1. Nessman DG, Carnahan JE, Nugent CA. Increasing compliance: patient operated hypertension groups. Archives of Internal Medicine 1980;140:1427‐1430. - PubMed
Park 1996 {published data only}
    1. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting: drug therapy monitoring and counseling by pharmacists contributed to improved blood pressure control in study patients. Journal of the American Pharmaceutical Association 1996;NS36(7):443‐451. - PubMed
Pierce 1984 {published data only}
    1. Pierce JP, Watson DS, Knights S, Gliddon T, Williams S, Watson R. A controlled trial of health education in the physicians's office. Preventive Medicine 1984;13:185‐194. - PubMed
Rehder 1980 {published data only}
    1. Rehder T, McCoy L, Blackwell W, Whitehead W, Robinson A. Improving medication compliance by counseling and special prescription calendar. American Journal of Hospital Pharmacy 1980;37:379‐85. - PubMed
Sackett 1975 {published data only}
    1. Sackett DL, Haynes RB, Gibson ES, Hackett BC, Taylor DW, Roberts RS, Johnson AL. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1975;1:1205‐1207. - PubMed
Saunders 1991 {published data only}
    1. Saunders LD, Irwig LM, Gear JS, Ramushu DL. A randomized controlled trial of compliance improving strategies in Soweto hypertensives. Medical Care 1991;29(7):669‐78. - PubMed
Sclar 1991 {published data only}
    1. Sclar DA, Chin A, Skaer TL, Okamoto MP, Nakahiro RK, Gill MA. Effect of health education in promoting prescription refill compliance among patients with hypertension. Clinical Therapy 1991;13(4):489‐95. - PubMed
Skaer 1993 {published data only}
    1. Skaer TL, Sclar DA, Markowski DJ, Won JKH. Effect of value‐added utilities on prescription refill compliance and health care expenditures for hypertension. Journal of Human Hypertension 1993;7:515‐18. - PubMed
Solomon 1998 {published data only}
    1. Solomon DK, Portner TS, Bass GE, Gourley DR, Gourley GA, k Holt JM. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. Journal of the American Pharmaceutical Association 1998;38:574‐85. - PubMed
Webb 1980 {published data only}
    1. Webb PA. Effectiveness of patient education and psychosocial counseling in promoting compliance and control among hypertensive patients. Journal of Family Practice. 10 1990; Vol. 10:1047‐55. - PubMed
Zarnke 1997 {published data only}
    1. Zarnke K, Feagan B, Mahon J, Feldman R. A randomized study comparing a patient‐directed hypertension management strategy with usual office‐based care. American Journal of Hypertension 1997;10:58‐67. - PubMed

References to studies excluded from this review

Binstock 1988 {published data only}
    1. Binstock ML, Franklin KL. A comparison of compliance techniques on the control of high blood pressure. American Journal of Hypertension 1988;1:192S‐194S. - PubMed
Casebeer 1995 {published data only}
    1. Casebeer L, Roesener GH. Patient informatics: using a computerized system to monitor patient compliance in the treatment of hypertension. Medinfo 1995;8(2):1500‐1502. - PubMed
Eisen 1990 {published data only}
    1. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Archives of Internal Medicine 1990;150(9):1881‐1884. - PubMed
Gonzalez‐Fern. 1990 {published data only}
    1. Gonzalez‐Fernandez RA, Rivera M, Torres D, Quiles J, Jackson A. Usefulness of a systemic hypertension in‐hospital educational program. Am J Cardiology 1990;65(20):1384‐6. - PubMed
Powers 1982 {published data only}
    1. Powers MJ, Wooldridge PJ. Factors influencing knowledge, attitudes, and compliance of hypertensive patients. Research in Nursing and Health 1982;5(4):171‐82. - PubMed
Strogatz 1983 {published data only}
    1. Strogatz DS, Earp JA. The determinants of dropping out of care among hypertensive patients receiving a behavioral intervention. Medical Care 1983;21(10):970‐80. - PubMed
Takala 1979 {published data only}
    1. Takala J, Niemela N, Rosti J, Sievers K. Improving compliance with therapeutic regimens in hypertensive patients in a community health centre. Circulation 1979;59(3):540‐3. - PubMed
Zismer 1982 {published data only}
    1. Zismer DK, Gillum RF, Johnson CA, Becerra J, Johnson TH. Improving hypertension control in private medical practice. Archives of Internal Medicine 1982;142(2):297‐299. - PubMed

Additional references

Berlin 1997
    1. Berlin JA, Miles CG, Crigliano MD. Does blinding of readers affect the results of meta‐analyses? Result of a randomized trial [letter]. The Lancet 1997;350:185‐186. - PubMed
Bowling 2001
    1. Bowling A, Ebrahim S. Measuring patients' preferences for treatment and perceptions of risk. Quality in Health Care 2001;10:i2‐i18. - PMC - PubMed
Burt 1995
    1. Burt VL, Cutler JA, Higgins M, Horan MF, Labarthe D, Whelton P, Brown C, Roccella E. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Hypertension 1995;26:60‐69. - PubMed
Caro 1995
    1. Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect on initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. Canadian Medical Association Journal 1999;160:41‐46. - PMC - PubMed
Colhoun 1994
    1. Colhoun HM, Dong W, Poulter NR. Blood pressue screening, management and control in England: results for the health survey for England 1994. Journal of Hypertension 1994;16:747‐752. - PubMed
Collins 1994
    1. Collins OR, Peto R. Antihypertensive drug therapy: effects on stroke and coronary heart disease. In: Swales JD editor(s). Textbook of hypertension. Oxford: Blackwell Scientific Publications, 1994:1156‐1164.
Dickersin 1994
    1. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. British Medical Journal 1994;309:1286‐91. - PMC - PubMed
Dowell 2002
    1. Dowell J, Jones A, Snadden D. Exploring medication use to seek concordance with 'non‐adherent' patients: a qualitative study. British Journal of General Practice 2002;52:24‐32. - PMC - PubMed
Dunbar‐Jacob 1991
    1. Dunbar‐Jacob J, Dwyer K, Dunning EJ. Compliance with antihypertensive regimen: a review of research in the 1980s. Annals of Behavioural Medicine 1991;13:31‐39.
Ebrahim 1998
    1. Ebrahim S. Detection, adherence and control of hypertension for the prevention of stroke: a systematic review. Health Technology Assessment 1998; Vol. 2, issue 11. - PubMed
HDFP 1984
    1. Hypertension Detection & Follow‐up Program. Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris, 5‐year findings of the hypertension detection and follow‐up program. Hypertension 1984;6:198‐206. - PubMed
HDFP 1986
    1. Hypertension Detection & Follow‐up Program. Results and implications of the Hypertension Detection & Follow‐up Program. Progress in Cardiovascular Disease 1986;29:1‐124. - PubMed
Juni 1999
    1. Juni P, Witschi A, Block R, Egger M. The hazards of scoring the quality of clinical trials for meta‐analysis. Journal of the American Medical Association 1999;282:1054‐1060. - PubMed
MacMahon 1990
    1. MacMahon S, Peto R, Cultler J, Collins R, Sorlie P, Neaton J, Abbot R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765‐774. - PubMed
McDonald 2002
    1. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002;288:2868‐79. - PubMed
Morrison 2000
    1. Morrison A, Wertheimer AI, Berger ML. Interventions to improve antihypertensive drug adherence: a quantitative review of trials. Hospital Formulary 2000;35:234‐255.
Psaty 1990
    1. Psaty BM, Koepsell TD, Wagner EH, Logerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping use of beta blockers. Journal of the Americal Medical Association 1990;263:1653‐1657. - PubMed
Rand 2000
    1. Rand C, Sevick MA. Ethics in adherence promoting and monitoring. Controlled Clinical Trials 2000;21:241S‐7S. - PubMed
Roter 1998
    1. Roter DL, Hall JA, Merisca R, Norstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta‐analysis. Medical Care 1998;36:1138‐1161. - PubMed
Sabate 2003
    1. Sabate E. Adherence to long‐term therapies: evidence for action. Geneva: World Health Organization, 2003.
Sieber 2000
    1. Sieber WJ, Kaplan RM. Informed adherence: the need for shared medical decision making. Controlled Clinical Trials 2000;21:233S‐40S. - PubMed
Thomson 2001
    1. Thomson R, Bowling A, Moss F. Engaging patients in decisions: a challenge to health care delivery and public health. Quality in Health Care 2001;10:i1. - PMC - PubMed
Urquhart 1997
    1. Urquhart J. The electronic medication event monitor ‐ lessons for pharmacotherapy. Clinical Pharmacokinetics 1997;32:345‐356. - PubMed
Working Party 1997
    1. Working Party on Concordance. From compliance to concordance ‐ achieving shared goals in medicine taking. London: Royal Pharmaceutical Society, 1997.

References to other published versions of this review

Schroeder 2003
    1. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure‐lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 2004;164(7):722‐32. - PubMed

Publication types

MeSH terms

Substances